Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, Recursion announced positive Phase 1b/2 results for REC-4881, which is its ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Google announced new branded queries filters are rolling out gradually within Google Search Console reporting. You can filter your performance reports by branded or non-branded queries and Google can ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

So far this year, electricity use in the US is up nearly 4 percent compared to the same period the year prior. That comes after decades of essentially flat use, a change that has been associated with ...

This tool helps to analyze the MySQL/MariaDB binary log files. The generated report will give an overview of how many UPDATE, INSERT, DELETE, DROP and TRUNCATE operations appear in the binary logs.

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. This was largely due to news from a ...

Community driven content discussing all aspects of software development from DevOps to design patterns. The goal of Hibernate and JPA is to hide the complexity of SQL and relational databases from the ...